Patents by Inventor Tobias ERB

Tobias ERB has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDES AND METHODS FOR THE CARBON-CARBON BOND FORMATION
    Publication number: 20220315968
    Abstract: The present invention relates to methods for the preparation of ?-hydroxyacyl compounds, and peptides for the catalyzed formation of ?-hydroxyacyl compounds as well as their use in the preparation of ?-hydroxyacyl compounds.
    Type: Application
    Filed: August 29, 2020
    Publication date: October 6, 2022
    Inventors: Tobias Erb, Simon Burgener
  • Carbon-neutral and carbon-positive photorespiration bypass routes supporting higher photosynthetic rate and yield
    Patent number: 10781456
    Abstract: The present invention relates to an organism, a tissue, a cell or an organelle expressing enzymes which allow the conversion of 2-phosphoglycolate (2-PG; also known as glycolate 2-phosphate,) into an intermediate compound of the Calvin-Benson-Bassham Cycle (CBBC) without releasing CO2. The organism, tissue, cell or organelle of the invention may be genetically engineered, transgenic and/or transplastomic so as to express at least one enzyme which is involved in this conversion. The present invention further relates to an organism, tissue, cell or organelle which comprises/expresses at least one enzyme which is involved in this conversion. The present invention further relates to a method for producing an organism, tissue, cell or organelle of the invention. The present invention further relates to a method of enzymatically converting 2-PG into an intermediate compound of the CBBC without releasing CO2.
    Type: Grant
    Filed: June 22, 2016
    Date of Patent: September 22, 2020
    Inventors: Arren Bar-Even, Tobias Erb, Steffen Lindner, Philippe Marliere, Dan S. Tawfik
  • CARBON-NEUTRAL AND CARBON-POSITIVE PHOTORESPIRATION BYPASS ROUTES SUPPORTING HIGHER PHOTOSYNTHETIC RATE AND YIELD
    Publication number: 20180223302
    Abstract: The present invention relates to an organism, a tissue, a cell or an organelle expressing enzymes which allow the conversion of 2-phosphoglycolate (2-PG; also known as glycolate 2-phosphate) into an intermediate compound of the Calvin-Benson-Bassham Cycle (CBBC) without releasing CO2. The organism, tissue, cell or organelle of the invention may be genetically engineered, transgenic and/or transplastomic so as to express at least one enzyme which is involved in this conversion. The present invention further relates to an organism, tissue, cell or organelle which comprises/expresses at least one enzyme which is involved in this conversion. The present invention further relates to a method for producing an organism, tissue, cell or organelle of the invention. The present invention further relates to a method of enzymatically converting 2-PG into an intermediate compound of the CBBC without releasing CO2.
    Type: Application
    Filed: June 22, 2016
    Publication date: August 9, 2018
    Applicants: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., Yeda Research and Development Co. Ltd., at the Weizmann Institute of Science
    Inventors: Arren BAR-EVEN, Tobias ERB, Steffen LINDNER, Philippe MARLIERE, Dan S. TAWFIK